The agency’s CHMP recommended drugs to treatments for hemophilia, two biosimilars for psoriasis, and two flu vaccines at their October meeting.

Johnson amp Johnson JampJ raised its 2024 profit and sales forecasts on October 15 thanks to strong sales of oncology drugs ...

The FDA has approved Imuldosa, a biosimilar to Stelara (ustekinumab), for the treatment of various chronic inflammatory diseases.

The following is a summary of “Single cell sequencing delineates T-cell clonality and pathogenesis of the parapsoriasis ...

FibroBiologics, Inc., (Nasdaq: FBLG) (“FibroBiologics”) and Charles River Laboratories (“Charles River”), a leading global drug discovery, development, testing, and manufacturing solutions provider ...

Research might produce treatments of involving transplants with a few, selected types of bacteria tailored to an individual's ...